7 Most pharmaceutical companies believe their Medical Legal Regulatory review process protects them from risk. In … Are Smart Compliance Systems Replacing Bottlenecks and Redefining Commercial Speed?Read more
Regulatory Compliance
Focused on FDA, PhRMA, MLR reviews, and legal guardrails for marketers.
The Hidden Compliance Risk of AI in Pharmaceutical Promotion
Pharmaceutical companies are adopting generative AI faster than regulators can write guidance. That gap is where … The Hidden Compliance Risk of AI in Pharmaceutical PromotionRead more
The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy
Drug price transparency laws are not just policy changes. They are forcing pharmaceutical companies to change … The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing StrategyRead more
FDA Draft Guidance on AI in Pharmaceutical Advertising: What Pharma Marketers Must Know Now
The pharmaceutical industry spent decades building tightly controlled promotional systems where every word in an advertisement … FDA Draft Guidance on AI in Pharmaceutical Advertising: What Pharma Marketers Must Know NowRead more
How Pharma Can Balance Compliance With Creativity
Innovation in the pharmaceutical industry requires creativity, experimentation, and bold scientific thinking. At the same time, … How Pharma Can Balance Compliance With CreativityRead more
How Compliance Fears Limit Effective Pharma Marketing in the U.S. Pharmaceutical Industry
In the United States, pharmaceutical marketing operates under some of the strictest regulatory scrutiny in the … How Compliance Fears Limit Effective Pharma Marketing in the U.S. Pharmaceutical IndustryRead more
Top 5 Reasons Biotech Companies Fail to Scale
Biotechnology has emerged as one of the most innovation-driven sectors in healthcare. Advances in gene therapy, … Top 5 Reasons Biotech Companies Fail to ScaleRead more
Why Pricing Pressure Is Reshaping Drug Commercialization
The United States pharmaceutical market has historically provided manufacturers with substantial pricing flexibility compared to other … Why Pricing Pressure Is Reshaping Drug CommercializationRead more
Why Many Drugs Fail Despite Positive Trial Results
Over 90 percent of drugs that show promise in early-phase clinical trials fail to reach the … Why Many Drugs Fail Despite Positive Trial ResultsRead more
Why Drugs Fail After Phase I in the U.S. Market
In the United States, roughly 12 percent of drugs that enter clinical testing ultimately receive approval … Why Drugs Fail After Phase I in the U.S. MarketRead more